建滔积层板因优先购股权获行使而发行合共1457.5万股

Core Points - The company Kintor Pharmaceutical announced that its directors exercised their pre-emptive rights on November 14, 2025, resulting in the issuance of 11.75 million shares [1] - Employees of the company also exercised their pre-emptive rights on the same date, leading to the issuance of 2.825 million shares [1] Summary by Category Share Issuance - Directors exercised pre-emptive rights resulting in 11.75 million shares being issued [1] - Employees exercised pre-emptive rights resulting in 2.825 million shares being issued [1] Plan Details - The share issuance is based on the pre-emptive rights plan adopted by the company on May 29, 2017 [1]